fda warning letters glp-1 compounders october 2025 Issues Against Online Sellers Why the FDA Issued 30

Key points Emerging therapies for Parkinson disease (PD) have focused largely on disease modification and on dopamine resistance symptoms, which are both important unmet needs

These changes usually start within three months of a stressful event

87 SinghA.BodasM.WakabayashiN.BunzF.BiswalS

In addition to worsening symptoms such as headache, dizziness, and vomiting mentioned above, ataxia, mental confusion, varying degrees of consciousness disorders, fever, and in severe cases, brain herniation can occur, endangering life (Li et al., 2023).The exact pathophysiological mechanisms underlying the development of AMS and HACE have not been fully determined

Additionally, ROS activates proinflammatory mediators, NRLP3 inflammasomes, and proatherogenic transcription factors